BrainChild Bio is a kids-first, clinical-stage biotechnology company specializing in CAR-T cell technology for central nervous system tumors. Focused on treating diffuse intrinsic pontine glioma (DIPG) in pediatrics and expanding to other brain tumors and metastases, the company aims to optimize CAR-T applications and advance therapies for both pediatric and adult patients.
BrainChild Bio is seeking an experienced Scientist in Analytical Development to lead a team in routine analytical testing and process development for CAR T therapies to treat pediatric brain malignancies.
BrainChild Bio is a kids-first, clinical-stage biotechnology company specializing in CAR-T cell technology for central nervous system tumors. Focused on treating diffuse intrinsic pontine glioma (DIPG) in pediatrics and expanding to other brain tumors and metastases, the company aims to optimize CAR-T applications and advance therapies for both pediatric and adult patients.
Umoja Biopharma